Streamlining whole genome sequencing for clinical diagnostics with ONT technology

被引:0
|
作者
Han-Chieh Wu [1 ]
Yueh-Tzu Chiu [1 ]
I-Ching Wu [2 ]
Ci-Hong Liou [1 ]
Hung-Wei Cheng [2 ]
Shu-Chen Kuo [1 ]
Tsai-Ling Lauderdale [1 ]
Huey-Kang Sytwu [1 ]
Yu-Chieh Liao [2 ]
Feng-Jui Chen [1 ]
机构
[1] National Health Research Institutes,National Institute of Infectious Diseases and Vaccinology
[2] National Health Research Institutes,Institute of Population of Health Sciences
[3] National Yang Ming Chiao Tung University,Department of Biological Science and Technology
关键词
D O I
10.1038/s41598-025-90127-8
中图分类号
学科分类号
摘要
Recent advances in whole-genome sequencing (WGS) have increased the accessibility of this tool, offering substantial potential for pathogen surveillance, outbreak response, and diagnostics. However, the routine clinical adoption of WGS is hindered by factors such as high costs, technical complexity, and the requirement for bioinformatics expertise for data analysis. To address these challenges, we propose RapidONT, a workflow designed for cost-effective and accessible WGS-based pathogen analysis. RapidONT employs a mechanical shearing–based DNA extraction protocol, followed by library construction by using a multiplexing Oxford nanopore technologies (ONT) rapid barcoding kit. Flye software is used for de novo assembly without manual intervention, followed by basic assembly polishing using Medaka and Homopolish. The polished assemblies are then analyzed using the user-friendly web-based platform Pathogenwatch, which facilitates species identification, molecular typing, and antimicrobial resistance (AMR) prediction, all while requiring minimal bioinformatics expertise. The efficacy of RapidONT was evaluated using nine clinically relevant pathogens, encompassing a total of 90 gram-positive and gram-negative bacterial strains. The workflow demonstrated high accuracy in critical tasks such as multilocus sequence typing (MLST) and AMR identification, using only ONT R9.4.1 flowcell data. Notably, limitations were observed with Salmonella spp. and Neisseria gonorrhoeae. Furthermore, RapidONT enabled the generation of genomic information for 48 bacterial isolates by using a single flow cell, significantly reducing sequencing costs. This approach eliminates the need for extensive experimentation in obtaining crucial genomic information. This workflow facilitates broader WGS implementation in clinical pathogen analysis and diagnostics.
引用
收藏
相关论文
共 50 条
  • [31] Clinical utility of whole genome sequencing for the detection of mitochondrial genome mutations
    Ammar Husami
    Jesse Slone
    Jenice Brown
    Meghan Bromwell
    C.Alexander Valencia
    Taosheng Huang
    Journal of Genetics and Genomics, 2020, 47 (03) : 167 - 169
  • [32] Challenges in the clinical application of whole-genome sequencing
    Ormond, Kelly E.
    Wheeler, Matthew T.
    Hudgins, Louanne
    Klein, Teri E.
    Butte, Atul J.
    Altman, Russ B.
    Ashley, Euan A.
    Greely, Henry T.
    LANCET, 2010, 375 (9727): : 1749 - 1751
  • [33] CLINICAL WHOLE GENOME SEQUENCING: THE SALVATION FOR DIAGNOSTIC ODYSSEYS?
    Shankar, S.
    Hagerman, R.
    Triano, V
    Rauen, K. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 180 - 180
  • [34] Clinical use of whole genome sequencing for Mycobacterium tuberculosis
    Adam A. Witney
    Catherine A. Cosgrove
    Amber Arnold
    Jason Hinds
    Neil G. Stoker
    Philip D. Butcher
    BMC Medicine, 14
  • [35] Whole genome sequencing in clinical and public health microbiology
    Kwong, J. C.
    McCallum, N.
    Sintchenko, V.
    Howden, B. P.
    PATHOLOGY, 2015, 47 (03) : 199 - 210
  • [36] Clinical use of whole genome sequencing for Mycobacterium tuberculosis
    Witney, Adam A.
    Cosgrove, Catherine A.
    Arnold, Amber
    Hinds, Jason
    Stoker, Neil G.
    Butcher, Philip D.
    BMC MEDICINE, 2016, 14
  • [37] Clinical Interpretation and Implications of Whole-Genome Sequencing
    Dewey, Frederick E.
    Grove, Megan E.
    Pan, Cuiping
    Goldstein, Benjamin A.
    Bernstein, Jonathan A.
    Chaib, Hassan
    Merker, Jason D.
    Goldfeder, Rachel L.
    Enns, Gregory M.
    David, Sean P.
    Pakdaman, Neda
    Ormond, Kelly E.
    Caleshu, Colleen
    Kingham, Kerry
    Klein, Teri E.
    Whirl-Carrillo, Michelle
    Sakamoto, Kenneth
    Wheeler, Matthew T.
    Butte, Atul J.
    Ford, James M.
    Boxer, Linda
    Ioannidis, John P. A.
    Yeung, Alan C.
    Altman, Russ B.
    Assimes, Themistocles L.
    Snyder, Michael
    Ashley, Euan A.
    Quertermous, Thomas
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (10): : 1035 - 1044
  • [38] Clinical whole-genome sequencing in cancer diagnosis
    Hou, Ying-Chen C.
    Neidich, Julie A.
    Duncavage, Eric J.
    Spencer, David H.
    Schroeder, Molly C.
    HUMAN MUTATION, 2022, 43 (11) : 1519 - 1530
  • [39] Implementation of clinical whole genome sequencing in paediatric epilepsy
    Henry, O. J.
    Ygberg, S.
    Barbaro, M.
    Lesko, N.
    Karlsson, L.
    Pena-Perez, L.
    Bergquist, A. Bavner
    Tohonen, V.
    Stranneheim, H.
    Lindstrand, A.
    Stodberg, T.
    Wedell, A.
    EPILEPSIA, 2024, 65 : 477 - 478
  • [40] Clinical Analysis of Whole Genome Sequencing in Cancer Patients
    Alison May Berner
    George J. Morrissey
    Nirupa Murugaesu
    Current Genetic Medicine Reports, 2019, 7 : 136 - 143